Showing promise in the field of weight management management, retatrutide represents a different strategy. Different from many existing medications, retatrutide operates as a dual agonist, simultaneously targeting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic polypeptide (GIP) sensors. This simultaneous stimulation promotes v